Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
Kathy Dujardin, Véronique Sgambato‐Faure
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Mapping the serum proteome to neurological diseases using whole genome sequencing
Grace Png, Andrei Barysenka, L. Repetto, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 43
Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies
Thuy Thi Lai, Birthe Gericke, Malte Feja, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Peripheral Upregulation of Parkinson’s Disease-Associated Genes Encoding α-Synuclein, β-Glucocerebrosidase, and Ceramide Glucosyltransferase in Major Depression
Razvan-Marius Brazdis, Claudia von Zimmermann, Bernd Lenz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3219-3219
Open Access | Times Cited: 5
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools
Luca Angelini, Giulia Paparella, Matteo Bologna
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 8, pp. 799-814
Closed Access | Times Cited: 5
Blockade of mGluR1 and mGluR5 in the lateral habenula produces the opposite effects in the regulation of depressive-like behaviors in the hemiparkinsonian rats
Kuncheng Liu, Yanping Hui, Yaxin Yang, et al.
Experimental Neurology (2025) Vol. 386, pp. 115154-115154
Closed Access
Can adenosine A2A receptor antagonists be used to treat cognitive impairment, depression or excessive sleepiness in Parkinson's disease?
Peter Jenner, Akihisa Mori, Tomoyuki Kanda
Parkinsonism & Related Disorders (2020) Vol. 80, pp. S28-S36
Open Access | Times Cited: 30
Psychiatric Manifestations of Neurological Diseases: A Narrative Review
Anthony Maristany, C Brianna, Cameron Murray, et al.
Cureus (2024)
Open Access | Times Cited: 3
Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis
Giulia Menculini, Elena Chipi, Federico Paolini Paoletti, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4440-4440
Open Access | Times Cited: 23
Progression in Parkinson's Disease: Variation in Motor and Non‐motor Symptoms Severity and Predictors of Decline in Cognition, Motor Function, Disability, and Health‐Related Quality of Life as Assessed by Two Different Methods
Paulo Bugalho, Filipa Ladeira, Raquel Barbosa, et al.
Movement Disorders Clinical Practice (2021) Vol. 8, Iss. 6, pp. 885-895
Open Access | Times Cited: 21
Association between CNS-active drugs and risk of Alzheimer’s and age-related neurodegenerative diseases
Helena Cortes‐Flores, Georgina Torrandell‐Haro, Roberta Dı́az Brinton
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation Analyses
Sarah M. Szymkowicz, Jacob D. Jones, Holly Timblin, et al.
American Journal of Geriatric Psychiatry (2021) Vol. 30, Iss. 6, pp. 664-674
Open Access | Times Cited: 14
The Impact of Depression Symptoms in Patients with Parkinson’s Disease: A Novel Case-Control Investigation
Ana María Jiménez‐Cebrián, Ricardo Vallejo, Marta Elena Losa‐Iglesias, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 5, pp. 2369-2369
Open Access | Times Cited: 13
Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease
Veronica Antipova, Carsten Holzmann, Alexander Hawlitschka, et al.
Toxins (2021) Vol. 13, Iss. 7, pp. 505-505
Open Access | Times Cited: 13
Motor Cortex Stimulation Reversed Hypernociception, Increased Serotonin in Raphe Neurons, and Caused Inhibition of Spinal Astrocytes in a Parkinson’s Disease Rat Model
Ana Carolina P. Campos, Miriã Benatti Berzuino, Gabriela R. Barbosa, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1158-1158
Open Access | Times Cited: 12
Associated factors and abnormal dorsal raphe nucleus connectivity patterns of freezing of gait in Parkinson’s disease
Lingling Lv, Hainan Zhang, Xuling Tan, et al.
Journal of Neurology (2022) Vol. 269, Iss. 12, pp. 6452-6466
Closed Access | Times Cited: 8
Relationship between sleep disorders and neuropsychiatric symptoms in Parkinson's disease: A narrative review
Anastasiia D. Shkodina, Tymur Iengalychev, К. А. Tarianyk, et al.
Acta Facultatis Medicae Naissensis (2022) Vol. 39, Iss. 3, pp. 259-274
Open Access | Times Cited: 8
Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers
Ioanna Pachi, Christos Koros, Athina Maria Simitsi, et al.
Parkinsonism & Related Disorders (2021) Vol. 91, pp. 1-8
Open Access | Times Cited: 10
Extract of Mallotus oppositifolius (Geiseler) Müll. Arg. increased prefrontal cortex dendritic spine density and serotonin and attenuated para-chlorophenylalanine-aggravated aggressive and depressive behaviors in mice
Kennedy Kwami Edem Kukuia, Frimpong Appiah, George J. Dugbartey, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Prevalence and Correlates of Psychiatric Comorbidity and Multimorbidity in Parkinson’s Disease and Atypical Parkinsonian Syndromes
Vinit Patel, Jaisoorya TS, Nitish Kamble, et al.
Journal of Geriatric Psychiatry and Neurology (2022) Vol. 36, Iss. 2, pp. 155-163
Closed Access | Times Cited: 6
Venoms As an Adjunctive Therapy for Parkinson’s Disease: Where are We Now and Where are We going?
Parisa Gazerani
Future Science OA (2020) Vol. 7, Iss. 2
Open Access | Times Cited: 8
Association of CLU gene polymorphism with Parkinson's disease in the Chinese Han population
Yuwan Lin, Lin Lü, Miaomiao Zhou, et al.
The Journal of Gene Medicine (2020) Vol. 23, Iss. 2
Closed Access | Times Cited: 6
Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature
Rajib Dutta
Journal of Neuroscience and Neurological Disorders (2023) Vol. 7, Iss. 2, pp. 027-057
Open Access | Times Cited: 2
The altered multiscale dynamics of spontaneous brain activity in depression with Parkinson’s disease
Zhu Liu, Dongning Su, Lingyan Ma, et al.
Neurological Sciences (2022) Vol. 43, Iss. 7, pp. 4211-4219
Open Access | Times Cited: 4
Breathing new life into neurotoxic-based monkey models of Parkinson's disease to study the complex biological interplay between serotonin and dopamine
Véronique Sgambato‐Faure
Progress in brain research (2020), pp. 265-285
Closed Access | Times Cited: 4
Docking Screens of Noncovalent Interaction Motifs of the Human Subtype-D2 Receptor–75 Schizophrenia Antipsychotic Complexes with Physicochemical Appraisal of Antipsychotics
Parisa Amani, Razieh Habibpour, Leila Karami, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 12, pp. 2218-2232
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top